Picture of Zhaoke Ophthalmology logo

6622 — Zhaoke Ophthalmology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Zhaoke Ophthalmology says Atropine Sulfate Eye Drops Accepted For Evaluation By Australia's TGA

Jan 13 (Reuters) - Zhaoke Ophthalmology Ltd 6622.HK:

ATROPINE SULFATE EYE DROPS ACCEPTED FOR EVALUATION BY THERAPEUTIC GOODS ADMINISTRATION OF AUSTRALIA

Further company coverage: 6622.HK

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zhaoke Ophthalmology

See all news